TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Cancer Advocacy: Deal Returns $3M to Office of Women’s Health, Spends $3.5M On Workshops August 1, 1997
TCL Archive RFP To Be Issued For Two More Neutron Therapy Facilities; Winners To Conduct Clinical Trials October 27, 1978
